Cargando…
An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer’s Patients
Alzheimer’s disease (AD) is a common neurodegenerative disease, mainly manifested by cognitive dysfunction. It seriously reduces the quality of life, and there is no ideal treatment strategy in clinical practice. Clinical studies on the treatment of AD with Ginkgo biloba L. leaf extract (EGb) have b...
Autores principales: | Liu, Haolong, Ye, Min, Guo, Hongzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047126/ https://www.ncbi.nlm.nih.gov/pubmed/32153388 http://dx.doi.org/10.3389/fphar.2019.01688 |
Ejemplares similares
-
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Nowak, Anna, et al.
Publicado: (2021) -
Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022) -
Ginkgo biloba extract EGb 761(®) improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial
por: Cui, Mei, et al.
Publicado: (2023) -
Ginkgo biloba leaf extract EGb 761(®) as a paragon of the product by process concept
por: Kulić, Žarko, et al.
Publicado: (2022) -
Ginkgo biloba extract and neural regeneration
Publicado: (2012)